| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 6,197,198 | 81,183,000 | 43.29% | ||
| 2 | LA JOLLA PHARMACEUTICAL CO | 3,191,165 | 55,941,000 | 29.83% | ||
| 3 | IGNYTA INC COM | 3,972,800 | 21,056,000 | 11.23% | ||
| 4 | Opko Health, Inc. | 14,000,000 | 19,355,000 | 10.32% | PRN | |
| 5 | BIOMARIN | 90,215 | 7,473,000 | 3.99% | ||
| 6 | CYCLACEL PHARMACEUTICALS INC COM PAR | 359,900 | 1,904,000 | 1.02% | ||
| 7 | Life Technologies Corp | 279,425 | 601,000 | 0.32% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-17-001142, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
